Literature DB >> 913919

Barbiturate-induced choleresis: possible independence from microsomal enzyme induction.

J P Capron, M Dumont, G Feldmann, S Erlinger.   

Abstract

The influence of four barbiturates, phenobarbital, barbital, thiopental, and pentobarbital, on bile secretion and on the hepatic microsomal system was studied in anesthetized rats. The barbiturates were injected intraperitoneally for 4 days and the animals were studied on the 5th day. It was found that: (1) phenobarbital, barbital, and thiopental, but not pentobarbital, significantly increased liver weight, cytochrome P-450 concentration in the liver, decreased pentobarbital sleeping time and induced a hypertrophy of the smooth endoplasmic reticulum in the hepatocytes at electron microscopy; (2) in contrast, the four barbiturates, including pentobarbital, significantly increased bile flow; this increase was attributed to an increase in the bile acid independent bile flow. There was no correlation between the increase in bile flow and the cytochrome P-450 concentration in the liver. It is concluded that the increase in bile flow observed after barbiturate treatment in the rat is possibly independent of the hepatic microsomal enzyme induction produced by these drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913919     DOI: 10.1159/000198045

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.

Authors:  R A Willson; F E Hart; J T Hew
Journal:  Dig Dis Sci       Date:  1981-01       Impact factor: 3.199

2.  Influence of phenylbutazone on bile flow in the rat.

Authors:  C Bussière-Leboeuf; L Merle; J Dangoumau; C Balabaud
Journal:  Experientia       Date:  1978-05-15

Review 3.  The effect of drugs on bile flow and composition. An overview.

Authors:  L Okolicsanyi; F Lirussi; M Strazzabosco; R M Jemmolo; R Orlando; G Nassuato; M Muraca; G Crepaldi
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.